Feb 6 (Reuters) - Immutep Ltd (IMM) :
- IMMUTEP REACHES ENROLMENT TARGET FOR INSIGHT-003 TRIAL IN 1ST LINE NSCLC
- IMMUTEP LTD - ADDITIONAL DATA IS EXPECTED THROUGHOUT CALENDAR YEAR 2023 AND WILL FURTHER INFORM OUR NEXT STEPS IN 1L NSCLC
- IMMUTEP LTD - PROMISING INITIAL EFFICACY RESULTS SHOWING A 72.7% RESPONSE RATE AND 90.9% DISEASE CONTROL RATE REPORTED AT SITC 2022
Feb 6 (Reuters) - Immutep Ltd (IMM) : IMMUTEP REACHES ENROLMENT...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.010(4.17%) |
Mkt cap ! $337.6M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.0¢ | $244.5K | 1.043M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 392012 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 126850 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| IMM (ASX) Chart |